EnzyTag has been set up as spin-out of EnzyPep BV

EnzyTag will continue the development of chemo-enzymatic procedures for manufacturing peptide-based NCEs and bioconjugates using EnzyPep’s proprietary peptiligase technology.  EnzyTag has an exclusive, world-wide and perpetual license to the technology.

We use cookies to ensure that our website runs as smoothly as possible and to analyze web traffic. If you continue to use the website, you agree with our Privacy Policy. I agree